Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy-Reference-Cited by-同舟云学术

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy

Published:2015-10-23 Issue:2 Volume:108 Page:djv310
ISSN:0027-8874
Container-title:Journal of the National Cancer Institute
language:en
Short-container-title:JNCI.J

Author:

Brastianos Priscilla K.,Shankar Ganesh M.,Gill Corey M.,Taylor-Weiner Amaro,Nayyar Naema,Panka David J.,Sullivan Ryan J.,Frederick Dennie T.,Abedalthagafi Malak,Jones Pamela S.,Dunn Ian F.,Nahed Brian V.,Romero Javier M.,Louis David N.,Getz Gad,Cahill Daniel P.,Santagata Sandro,Curry William T.,Barker Fred G.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/108/2/djv310/17986121/djv310.pdf

Reference16 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

2. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas

3. Papillary craniopharyngioma: a clinicopathological study of 48 cases

4. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas

5. Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study;European Journal of Endocrinology;2024-08

2. Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications;Endocrine Reviews;2024-07-26

3. Approach to the Patient: New Era Emerges for Craniopharyngioma Management;The Journal of Clinical Endocrinology & Metabolism;2024-07-23

4. Topography and Radiological Variables as Ancillary Parameters for Evaluating Tissue Adherence, Hypothalamic–Pituitary Dysfunction, and Recurrence in Craniopharyngioma: An Integrated Multidisciplinary Overview;Cancers;2024-07-13

5. Targeted therapy in BRAF mutated aggressive papillary craniopharyngioma: a case report and overview of the literature;Journal of Endocrinological Investigation;2024-05-02